162 related articles for article (PubMed ID: 24262935)
41. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds.
Glienke W; Chow KU; Bauer N; Bergmann L
Leuk Lymphoma; 2006 Aug; 47(8):1629-38. PubMed ID: 16966277
[TBL] [Abstract][Full Text] [Related]
42. Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism.
Doudican NA; Bowling B; Orlow SJ
Leuk Res; 2010 Feb; 34(2):229-34. PubMed ID: 19540589
[TBL] [Abstract][Full Text] [Related]
43. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
Sahu GR; Jena RK
Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription.
Ghaffari SH; Momeny M; Bashash D; Mirzaei R; Ghavamzadeh A; Alimoghaddam K
Hematology; 2012 Jul; 17(4):198-206. PubMed ID: 22944098
[TBL] [Abstract][Full Text] [Related]
45. Integrating microRNA and mRNA expression profiles of acute promyelocytic leukemia cells to explore the occurrence mechanisms of differentiation syndrome.
Zhang Y; Hou J; Ge F; Cao F; Li H; Wang P; Xu M; Song P; Li X; Wang S; Li J; Han X; Zhao Y; Su Y; Li Y; Fan S; Li L; Zhou J
Oncotarget; 2016 Nov; 7(45):73509-73524. PubMed ID: 27634874
[TBL] [Abstract][Full Text] [Related]
46. Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
Roszak J; Smok-Pieniążek A; Stępnik M
Adv Clin Exp Med; 2017 Dec; 26(9):1335-1342. PubMed ID: 29442453
[TBL] [Abstract][Full Text] [Related]
47. Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation.
Yuksel S; Saydam G; Uslu R; Sanli UA; Terzioglu E; Buyukececi F; Omay SB
Leuk Res; 2002 Apr; 26(4):391-8. PubMed ID: 11839383
[TBL] [Abstract][Full Text] [Related]
48. Effect of myeloperoxidase inhibition on gene expression profiles in HL-60 cells exposed to 1,2,4,-benzenetriol.
Miyahara E; Nishikawa T; Takeuchi T; Yasuda K; Okamoto Y; Kawano Y; Horiuchi M
Toxicology; 2014 Mar; 317():50-7. PubMed ID: 24530881
[TBL] [Abstract][Full Text] [Related]
49. Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes.
Duan XF; Wu YL; Xu HZ; Zhao M; Zhuang HY; Wang XD; Yan H; Chen GQ
Chem Biol Interact; 2010 Jan; 183(1):222-30. PubMed ID: 19781537
[TBL] [Abstract][Full Text] [Related]
50. Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide.
Li Y; Feng L; Li Y; Jiang W; Shan N; Wang X
Leuk Lymphoma; 2014 Jun; 55(6):1366-72. PubMed ID: 23906016
[TBL] [Abstract][Full Text] [Related]
51. Investigating critical genes and gene interaction networks that mediate cyclophosphamide sensitivity in chronic myelogenous leukemia.
He X; Deng Y; Yue W
Mol Med Rep; 2017 Jul; 16(1):523-532. PubMed ID: 28560425
[TBL] [Abstract][Full Text] [Related]
52. EVI-1 modulates arsenic trioxide induced apoptosis through JNK signalling pathway in leukemia cells.
Lang W; Zhu J; Chen F; Cai J; Zhong J
Exp Cell Res; 2019 Jan; 374(1):140-151. PubMed ID: 30472098
[TBL] [Abstract][Full Text] [Related]
53. [p15 gene expression in acute lymphoblastic leukemia cell line Molt4 induced by arsenic trioxide].
Jin H; Lou F; Yu L
Zhonghua Xue Ye Xue Za Zhi; 2001 Jan; 22(1):24-6. PubMed ID: 11877046
[TBL] [Abstract][Full Text] [Related]
54. Construction of a metabolomics profile of arsenic trioxide effect in gastric carcinoma cell line SGC7901.
Chen Z; Zhang H; Yang L; Jiang H; Guo S; Li Y; Tao S
Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):474-81. PubMed ID: 27044562
[TBL] [Abstract][Full Text] [Related]
55. Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo.
Zhou P; Kalakonda N; Comenzo RL
Br J Haematol; 2005 Mar; 128(5):636-44. PubMed ID: 15725085
[TBL] [Abstract][Full Text] [Related]
56. Protein-protein interaction network and significant gene analysis of osteoporosis.
Wu XM; Ma X; Tang C; Xie KN; Liu J; Guo W; Yan YL; Shen GH; Luo EP
Genet Mol Res; 2013 Oct; 12(4):4751-9. PubMed ID: 24222250
[TBL] [Abstract][Full Text] [Related]
57. Arsenic in leukemia: a RSKy business.
Dent P
Cancer Biol Ther; 2013 Oct; 14(10):871-2. PubMed ID: 24025257
[TBL] [Abstract][Full Text] [Related]
58. [Effect of arsenic trioxide on the expression of cyclins gene in HL60 cells].
Jia JS; Xu SR; Ma J; Jia CR; Yao YR; Wang Y
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):113-6. PubMed ID: 12783709
[TBL] [Abstract][Full Text] [Related]
59. Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.
Biswas S; Zhao X; Mone AP; Mo X; Vargo M; Jarjoura D; Byrd JC; Muthusamy N
Leuk Res; 2010 Jul; 34(7):925-31. PubMed ID: 20171736
[TBL] [Abstract][Full Text] [Related]
60. Double-Sided Personality: Effects of Arsenic Trioxide on Inflammation.
Zhang J; Zhang Y; Wang W; Li C; Zhang Z
Inflammation; 2018 Aug; 41(4):1128-1134. PubMed ID: 29629493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
